Evidence map›Paper›PMID 42364242›Full record

ArticleJournal of industrial microbiology & biotechnology2026

Engineering Escherichia coli to produce medium chain oleochemicals from C2 substrates.

Sri Harsha Adusumilli, Shivangi Mishra, Brian F Pfleger

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sri Harsha AdusumilliDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID 0000-0001-8614-0802
Shivangi MishraDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID 0009-0001-8440-2749
Brian F PflegerDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States.ORCID 0000-0002-9232-9959

Funding

Advanced Research Projects Agency - EnergyU.S. Department of Energy DE-AR0001503
6 · The paper itself

Abstract

Many strategies to create a circular bioeconomy have been proposed. To be successful, CO2 must be reduced with renewable energy into chemical building blocks, from which the chemical industry can be supported. Circular strategies include leveraging photosynthesis to produce sugar and lipid intermediates or renewable electricity to produce hydrogen or other electron carriers to support CO2 reduction. Acetogens can anaerobically reduce CO2 with H2 to produce mixtures of small organic molecules in gas fermentations. We previously demonstrated that acetate, a common product of gas fermentation, can be converted to the model oleochemical dodecanol in engineered Escherichia coli. Here, we explored the conversion of ethanol and mixtures of ethanol and acetate to the same model oleochemicals. Co-feeding ethanol can supply both carbon and additional reducing power relative to acetate alone. In this work, we engineered E. coli to catabolize ethanol and expressed two distinct ethanol metabolism pathways in different operons and combined them with improved engineered acetate activation. We evaluated the performance of these operons in dodecanol-producing strains when fed ethanol or acetate and found ethanol to be a better carbon source when judged by product titers. The engineered strains fed ethanol produced about two-fold more dodecanol than the strains fed acetate. This increase was in part, due to change in product distribution. Cells fed ethanol produced predominantly dodecanol, whereas cells fed acetate generated a mixture of dodecanol and dodecanoic acid. Dodecanol titers were further improved by employing feeding strategies in controlled bioreactors.

Indexed as

DodecanolEscherichia coliEthanolMetabolic EngineeringAcetatesFermentationAcetatesDodecanolEthanolEscherichia coliethanol utilizationfatty alcoholsredox balancesubstrate optimization

Identifiers

PMID42364242
PMCPMC13373575

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.